Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17173364 | 0.86 | CA4 (0.46) | KIF11ALDH1A1KMT2A | |
| SCHEMBL21562153 | 0.86 | CA4 (0.46) | KIF11ALDH1A1KMT2A | |
| SCHEMBL16062155 | 0.81 | ALDH1A1 (0.41) | MAPK1KIF11ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL8813285 | 0.81 | MAPK1 (0.39) | MAPK1KIF11ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL11154095 | 0.80 | MAPK1 (0.42) | MAPK1ALDH1A1ALOX15CYP2D6CYP1A2 | |
| SCHEMBL3416867 | 0.79 | IRAK4 (0.38) | ALDH1A1GAANPSR1 | |
| SCHEMBL13641887 | 0.78 | MAPK1 (0.46) | MAPK1ALDH1A1ALOX15CYP2D6CYP1A2 | |
| SCHEMBL7153634 | 0.78 | MAPK1 (0.58) | MAPK1ALDH1A1ALOX15CYP2D6CYP1A2 | |
| SCHEMBL5899999 | 0.78 | ALDH1A1 (0.39) | MAPK1KIF11ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL8812383 | 0.78 | MAPK1 (0.41) | MAPK1KIF11ALDH1A1ALOX15KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284851-A1 | SILANE-TERMINATED POLYMERS | MERZ + BENTELI AG (CH) | 2023-12-06 | — | — | EP | claimed |
| WO-2022162106-A1 | SILANE-TERMINATED POLYMERS | MERZ + BENTELI AG (CH) | 2022-08-04 | — | — | WO | claimed |
| US-20230242571-A1 | SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-08-03 | — | — | US | disclosed |
| US-20230242571-A1 | SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-08-03 | — | — | US | disclosed |
| WO-2023107673-A2 | CLEAVABLE DISULFIDE LINKERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230160001-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-05-25 | — | — | US | disclosed |
| US-20230160001-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-05-25 | — | — | US | disclosed |
| US-20230119408-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-04-20 | — | — | US | disclosed |
| US-20230002436-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-01-05 | — | — | US | disclosed |
| US-11535754-B2 | Silicon containing detectable compounds and uses thereof | Singular Genomics Systems, Inc. (US) | 2022-12-27 | — | — | US | disclosed |
| US-11174281-B1 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2021-11-16 | — | — | US | disclosed |
| WO-2021226327-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-2749566-B1 | SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE | AIST (JP) | 2018-05-09 | — | — | EP | disclosed |
| US-9428809-B2 | Solid-phase carrier for aminated oligonucleotide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20140187724-A1 | SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-07-03 | — | — | US | disclosed |
| EP-2749566-A1 | SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE | National Institute of Advanced Industrial Science And Technology (JP) | 2014-07-02 | — | — | EP | disclosed |
| EP-1908829-B1 | OLIGONUCLEOTIDE PROBE | NAT INST OF ADVANCED IND SCIEN (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-7491857-B2 | Oligonucleotide probe | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20080227968-A1 | Oligonucleotide Probe | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-18 | — | — | US | disclosed |
| EP-1908829-A1 | OLIGONUCLEOTIDE PROBE | National Institute of Advanced Industrial Science and Technology (JP) | 2008-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119408-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | NUDT1, PNP, NT5C2 | MAPK1 4725/4885KIF11 4103/4885ALDH1A1 1275/4885 |
| US-20230002436-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | NUDT1, RNMT, ADAR | MAPK1 4820/4885KIF11 3775/4885ALDH1A1 1149/4885 |
| US-11174281-B1 | Modified nucleotides and uses thereof | NUDT1, RNMT, ADAR | MAPK1 4820/4885KIF11 3775/4885ALDH1A1 1149/4885 |
| US-20230242571-A1 | SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS | NSUN2, DCLRE1A, POLI | MAPK1 3446/4885KIF11 1184/4885ALDH1A1 4239/4885 |
| US-20080227968-A1 | Oligonucleotide Probe | APEX1, RNGTT, RNASEH1 | MAPK1 2022/4885KIF11 3783/4885ALDH1A1 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.